Search with one or more keywords

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml
XML

Export to XML

Please choose the format :

XML
XML-DDI
pdf
PDF

Export to PDF

Which version do you want to export ?

Download full content
Download light content
csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection
Export to CSV

Covid-19 : 82 forms

Sorting of results :

NICORISCOVID - Measurement of the strength of the relationship between tobacco use and the RT-PCR test for SARS-CoV2

Head : KARMOCHKINE Marina, no

Version 1
Voir
View
Overview

25

Last update : 05/05/2021

NICORISCOVID - Measurement of the strength of the relationship between tobacco use and the RT-PCR test for SARS-CoV2

Head : KARMOCHKINE Marina, no

Main objective

Measure the strength of the relationship between tobacco use and the RT-PCR test for SARS-CoV2

Inclusion criteria

Care personnel having attended the Hôtel-Dieu Hospital Covid screening centre for symptoms compatible with SARS-CoV2 infection,
-Aged over 18 years,
With an email address,
-Able to express non-objection (=questionnaire feedback

Last update : 05/05/2021

Voir
View

SARCODO - Evaluation of coagulopathy and endothelial dysfunction as a predictive factor for the severity of SARS-CoV-2/COVID-19 infection

Head : SMADJA David, UMR-S1140 and Biosurgical Research Laboratory (Carpentier Foundation)

Version 1
Voir
View
Overview

26

Last update : 05/05/2021

SARCODO - Evaluation of coagulopathy and endothelial dysfunction as a predictive factor for the severity of SARS-CoV-2/COVID-19 infection

Head : SMADJA David, UMR-S1140 and Biosurgical Research Laboratory (Carpentier Foundation)

Main objective

Study the coagulopathy, vascular lesion and markers for tissue distress to characterise the exacerbation of patients with COVID-19 and identify patient populations who will develop or experience exacerbation of a thromboembolic or microvascular process, but also require curative anticoagulation.

Inclusion criteria

Patients aged at least 18 years
Hospitalised in an intensive care or medicine department for suspected COVID-19.
Patients covered by a social security regime (other than the state welfare scheme)
Patient having been informed of the study and having given their informed consent in writing, or for whom a family member/trusted person has given their agreement

Last update : 05/05/2021

Voir
View

SISCOVID - Observational, prospective, multicentre cohort of patients followed up after hospitalisation to evaluate respiratory sequelae subsequent to SARS-CoV-2 (COVID-19) infection

Head : CALCAIANU George

Version 1
Voir
View
Overview

27

Last update : 05/03/2021

SISCOVID - Observational, prospective, multicentre cohort of patients followed up after hospitalisation to evaluate respiratory sequelae subsequent to SARS-CoV-2 (COVID-19) infection

Head : CALCAIANU George

Main objective

Evaluate the respiratory sequelae after SARS-CoV-2 infection in patients hospitalised for severe COVID-19 pneumonia requiring O2, with subsequent outpatient follow-up (6 months) by:
- Low-dose chest CT scan (LD-chest CT),
- Static lung function tests (LFT),
- Arterial blood gases in ambient air at rest (AA BG) and/or with oxygen (O2 BG),
- 6-minute walking test in ambient air (6WT AA) and/or with oxygen (6WT O2)

Inclusion criteria

Patient having received verbal information and not objecting to the study
Age >= 18 years inclusive
Patient hospitalised for severe COVID-19 pneumonia requiring O2
Patient having contracted SARS-CoV-2 infection proven by RT-PCR and/or retrospective serology and/or COVID-19 syndrome with chest CT scan consistent with infection (over the period from 1 March 2020 to 30 June 2020)

Last update : 05/03/2021

Voir
View

PIANO COVID-19 - Effect of organizational measures to prevent and control COVID-19 infection in nursing homes on the risk of death of residents during and after the epidemic period - PIANO COVID-19

Head : ROLLAND Yves

Version 1
Voir
View
Overview

28

Last update : 04/21/2021

PIANO COVID-19 - Effect of organizational measures to prevent and control COVID-19 infection in nursing homes on the risk of death of residents during and after the epidemic period - PIANO COVID-19

Head : ROLLAND Yves

Main objective

The main objective is to compare the occurrence of global death of residents during a 1-year period (from January 2020 to December 2020) in NH and LTCU with a high level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU residents’ infection and NH and LTCU with a low level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU.

The secondary objectives are:
- To compare the rate of death related to confirmed or suspected COVID cases in NH/LTCU with a high level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU residents’ infection and NH/LTCU with a low level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU.
- To compare the rate of death not related to COVID cases in NH/LTCU with a high level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU residents’ infection and NH/LTCU with a low level of implementation of the recommendation/guidance to prevent and control COVID-19 NH/LTCU.
- To analyze the incidence of serious health events (deaths, hospitalizations) and the occurrence of COVID in residents (vaccinated and unvaccinated), in NHs and LTCUs in France during a 12-month (2021) observation period.
- To analyze the occurrence of COVID in residents (vaccinated and unvaccinated), in NHs and LTCUs in France according to the rate of vaccination against COVID among the NH’s/LTCU’s staff during the same observational period.
From an economic perspective:
- To assess the economic impact of the implementation of prevention measures applied by nursing homes staff, from healthcare system and the NH perspectives, 6, and 12 months before and 6, 12 months to 24 months after the implementation of the preventive measures.
- To assess the economic impact of the vaccination among residents and NH’staff, from healthcare system and the NH perspectives, 6 and 12 months before and after the vaccination campaign. These data will also provide indirect economic information about the tolerance of the vaccination.
- To assess the efficiency of the high level implementation of the recommendation to prevent and control COVID-19 in comparison with the low level implementation of recommendation to prevent and control COVID-19, using a cost-effectiveness analysis at 12 and 24 months.
- To assess the efficiency of the vaccination, at 6 and 12 months, among residents and healthcare professionals in comparison with no vaccination, using a cost-effectiveness analysis

Inclusion criteria

NHs and LTCU volunteers to participate from different region of France (from low impacted to highly impacted region) will be welcomed.
NON-INCLUSION CRITERIA
NHs or LTCUs that refuse to participate.

Last update : 04/21/2021

Voir
View

CERTIFY.HEALTH - Evaluation of the Certify.Health application as a digital resource for managing the COVID-19 pandemic

Head : BOSSON Jean-Luc, TIMC Laboratory - Themas team

Version 1
Voir
View
Overview

29

Last update : 05/05/2021

CERTIFY.HEALTH - Evaluation of the Certify.Health application as a digital resource for managing the COVID-19 pandemic

Head : BOSSON Jean-Luc, TIMC Laboratory - Themas team

Main objective

Evaluate the user-friendliness and acceptability of the Certify.Health application among healthcare personnel in healthcare, research and teaching facilities

Inclusion criteria

- Age ≥ 18 years
- Healthcare personnel in healthcare, research and teaching facilities, or a member of the home-care network:
• equipped with a smartphone which can run the electronic application (version of the participant’s Android or iOS operating system compatible with the application) and having an internet connection OR a computer with internet access
• agreeing to provide their mobile phone number to access the application and receive notifications
OR a resident in a selected nursing home

Last update : 05/05/2021

Voir
View

ComCor - Study of sociodemographic factors, behaviours and practices associated with SARS-CoV-2 infection (ComCor)

Head : Fontanet Arnaud, Emerging Diseases Epidemiology Unit

Version 1
Voir
View
Overview

30

Last update : 05/07/2021

ComCor - Study of sociodemographic factors, behaviours and practices associated with SARS-CoV-2 infection (ComCor)

Head : Fontanet Arnaud, Emerging Diseases Epidemiology Unit

Main objective

Identify the sociodemographic characteristics, places frequented, and behaviours associated with a risk of SARS-CoV-2 infection.

Inclusion criteria

All subjects:
o Adult subject
o Having agreed to take part in the study
o Index case:
o Cases identified in the COVID-19 screening information
system database, SIDEP
o With a positive test for SARS-CoV-2 by
RT-PCR on a nasopharyngeal or throat swab (or
any other sample for which current technology
indicates active infection if positive) within the past 14
days
o Close contact cases:
o Living in the same household (sharing the same
home) as the case having invited him/her to take part
o With a positive test for SARS-CoV-2 by RT-PCR on a nasopharyngeal or
throat swab (or any other sample for which current technology
indicates active infection if positive)
following contact with the index case
o Close contact controls:
o Living in the same household (sharing the same
home) as the case having invited him/her to take part
o With a negative test for SARS-CoV-2 by RT-PCR on a nasopharyngeal or
throat swab (or any other sample for which current technology
indicates active infection if positive)
following contact with the index case
o Distant contact controls:
o Selected by IPSOS based on criteria including age,
gender, and administrative department of residence (paired
with index cases)

Last update : 05/07/2021

Voir
View

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05